Cargando…
Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas
OBJECTIVE: This study sought to determine whether pretreatment pan-immune-inflammation value (PIV) could be used to predict prognosis in patients with locally advanced pancreatic adenocarcinoma (LA-PAC) following definitive concurrent chemoradiotherapy (C-CRT). METHODS: The outcomes of 178 LA-PAC pa...
Autores principales: | Topkan, Erkan, Selek, Ugur, Kucuk, Ahmet, Pehlivan, Berrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499729/ https://www.ncbi.nlm.nih.gov/pubmed/36158517 http://dx.doi.org/10.2147/JIR.S385328 |
Ejemplares similares
-
A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer
por: Kucuk, Ahmet, et al.
Publicado: (2023) -
High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients
por: Kucuk, Ahmet, et al.
Publicado: (2022) -
The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
por: Yilmaz, Busra, et al.
Publicado: (2023) -
Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2020) -
The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
por: Kucuk, Ahmet, et al.
Publicado: (2020)